The American-Japanese company MicroVention-Terumo, from the life sciences sector, announced that it will expand its operations in Costa Rica with the construction of its new plant in the Coyol Free Zone, in Alajuela, of 20,000 square meters and which will generate soon 2,000 new jobs in various administrative, operational and engineering areas.
Currently, MicroVention employs 1,700 people, its new investment will be close to US $ 80 million by the end of 2022.
The announcement was made during a visit by the President of the Republic, Carlos Alvarado, the Minister of Foreign Trade, Andrés Valenciano, and the General Director of CINDE, Jorge Sequeira to the company’s facilities.
After reiterating the government’s support for foreign direct investment and the Free Trade Zone regime, Alvarado commented that “this announcement by MicroVention, of increasing its payroll by 2,000 jobs and opening a third plant represents a great impact on the generation of quality employment in the country ”and highlighted the inter-institutional work that has been carried out, and that will be strengthened with the new INA Law, to train Costa Ricans so that they have greater opportunities to enter the labor market.
Microvention began operations in Costa Rica more than 7 years ago and has recognized the great potential of our family of workers and managers, as well as manufacturing associates. Our success in Costa Rica has allowed MicroVention to grow in what is our third expansion in the country. Today our strategic vision drives us to close 2022 with nearly 35,000 square meters in manufacturing areas and 3,000 employees. We are very proud to export medical products from Costa Rica all over the world, in addition to helping patients have a better quality of life, “said Charlie Noel, Vice President of International Operations at MicroVention.